Inflammation in the Spotlight-clinical Relevance of Genetic Variants Affecting Nuclear Factor κB and Tumor Necrosis Factor Receptor 1

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2017 Jun 13

PMID 28603734

Citations 1

Authors

Francisco J Ortega

Jose M Fernandez-Real

Affiliations

Soon will be listed here.

Citing Articles

Transplantation of neural precursors generated from spinal progenitor cells reduces inflammation in spinal cord injury via NF-κB pathway inhibition.

Karova K, Wainwright J, Machova-Urdzikova L, Pisal R, Schmidt M, Jendelova P J Neuroinflammation. 2019; 16(1):12.

PMID: 30654804 PMC: 6335809. DOI: 10.1186/s12974-019-1394-7.

References

Hawkes C, MacGregor A . Twin studies and the heritability of MS: a conclusion. Mult Scler. 2009; 15(6):661-7. DOI: 10.1177/1352458509104592. View

Hemminki K, Li X, Sundquist J, Hillert J, Sundquist K . Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions. Neurogenetics. 2008; 10(1):5-11. DOI: 10.1007/s10048-008-0156-y. View

Atzeni F, Talotta R, Salaffi F, Cassinotti A, Varisco V, Battellino M . Immunogenicity and autoimmunity during anti-TNF therapy. Autoimmun Rev. 2012; 12(7):703-8. DOI: 10.1016/j.autrev.2012.10.021. View

Sawcer S, Hellenthal G, Pirinen M, Spencer C, Patsopoulos N, Moutsianas L . Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011; 476(7359):214-9. PMC: 3182531. DOI: 10.1038/nature10251. View

Gregory A, Dendrou C, Attfield K, Haghikia A, Xifara D, Butter F . TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature. 2012; 488(7412):508-511. PMC: 4268493. DOI: 10.1038/nature11307. View

Patterson H, Nibbs R, McInnes I, Siebert S . Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases. Clin Exp Immunol. 2013; 176(1):1-10. PMC: 3958149. DOI: 10.1111/cei.12248. View

Hemmer B, Hartung H . Toward the development of rational therapies in multiple sclerosis: what is on the horizon?. Ann Neurol. 2007; 62(4):314-26. DOI: 10.1002/ana.21289. View

Hirahara K, Schwartz D, Gadina M, Kanno Y, OShea J . Targeting cytokine signaling in autoimmunity: back to the future and beyond. Curr Opin Immunol. 2016; 43:89-97. DOI: 10.1016/j.coi.2016.10.001. View

Ozenci V, Kouwenhoven M, Huang Y, Kivisakk P, Link H . Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment. Clin Exp Immunol. 2000; 120(1):147-53. PMC: 1905623. DOI: 10.1046/j.1365-2249.2000.01175.x. View

10.

Ramanan V, Saykin A . Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. Am J Neurodegener Dis. 2013; 2(3):145-75. PMC: 3783830. View

11.

Sun X, Zhang H . NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol. 2007; 22(12):1387-98. DOI: 10.14670/HH-22.1387. View

12.

Cotsapas C, Voight B, Rossin E, Lage K, Neale B, Wallace C . Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet. 2011; 7(8):e1002254. PMC: 3154137. DOI: 10.1371/journal.pgen.1002254. View

13.

Ortiz G, Pacheco-Moises F, Bitzer-Quintero O, Ramirez-Anguiano A, Flores-Alvarado L, Ramirez-Ramirez V . Immunology and oxidative stress in multiple sclerosis: clinical and basic approach. Clin Dev Immunol. 2013; 2013:708659. PMC: 3794553. DOI: 10.1155/2013/708659. View

14.

Sun S . Non-canonical NF-κB signaling pathway. Cell Res. 2010; 21(1):71-85. PMC: 3193406. DOI: 10.1038/cr.2010.177. View

15.

Srinivasan M, Lahiri D . Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis. Expert Opin Ther Targets. 2015; 19(4):471-87. PMC: 5873291. DOI: 10.1517/14728222.2014.989834. View

16.

Heinz S, Romanoski C, Benner C, Allison K, Kaikkonen M, Orozco L . Effect of natural genetic variation on enhancer selection and function. Nature. 2013; 503(7477):487-92. PMC: 3994126. DOI: 10.1038/nature12615. View

17.

van Delft M, Huitema L, Tas S . The contribution of NF-κB signalling to immune regulation and tolerance. Eur J Clin Invest. 2015; 45(5):529-39. DOI: 10.1111/eci.12430. View

18.

Alvarez S, Harikumar K, Hait N, Allegood J, Strub G, Kim E . Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature. 2010; 465(7301):1084-8. PMC: 2946785. DOI: 10.1038/nature09128. View

19.

Caminero A, Comabella M, Montalban X . Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis. Clin Exp Immunol. 2011; 166(3):338-45. PMC: 3232381. DOI: 10.1111/j.1365-2249.2011.04484.x. View

20.

Srinivasan K, Friedman B, Larson J, Lauffer B, Goldstein L, Appling L . Untangling the brain's neuroinflammatory and neurodegenerative transcriptional responses. Nat Commun. 2016; 7:11295. PMC: 4844685. DOI: 10.1038/ncomms11295. View